tiprankstipranks
Trending News
More News >
Relmada Therapeutics (RLMD)
NASDAQ:RLMD

Compare Relmada Therapeutics (RLMD) vs. Competitors

Compare
428 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Relmada Therapeutics
$6.07
$636.68M
-3.32
1909.93%
3 Buy
0 Hold
0 Sell
Strong Buy
XBiotech
$2.39
$72.87M
-0.68
-30.72%
Prelude Therapeutics
$2.45
$188.38M
-2.24
306.25%
1 Buy
0 Hold
0 Sell
Moderate Buy
Spruce Biosciences
$58.40
$80.13M
-1.71
131.76%
3 Buy
0 Hold
0 Sell
Strong Buy
Werewolf Therapeutics
$0.79
$38.15M
-1.37
-27.89%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RLMD
Relmada Therapeutics
6.07
5.77
1923.33%
XBIT
XBiotech
2.39
-1.07
-30.92%
RPTX
PRLD
Prelude Therapeutics
2.99
2.27
315.28%
SPRB
Spruce Biosciences
58.40
33.66
136.05%
HOWL
Werewolf Therapeutics
0.79
-0.33
-29.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts